Fanny Gonzales

Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications

C. Preudhomme, M. Cheok, F. Gonzales, 2021, Expert opinion on therapeutic targets.

Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.

A. Duhamel, P. Schneider, E. Thébaud, 2021, The Lancet. Child & adolescent health.

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment

H. Dombret, C. Preudhomme, N. Boissel, 2020, International journal of molecular sciences.

Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021, Journal of Cancer Research and Clinical Oncology.

Improved Outcome in Young Children Compared to Adolescents and Adults After Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia: a Retrospective Study From Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021 .

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up.

B. Quesnel, A. Plesa, C. Preudhomme, 2018, Journal of visualized experiments : JoVE.

Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia

A. Plesa, C. Preudhomme, C. Berthon, 2023, bioRxiv.

Antithymocyte globulin in pediatric allogeneic hematopoietic stem cell transplantation: Infusion time and tolerability

F. Machuron, B. Bruno, F. Gonzales, 2020, Pediatric transplantation.